PRODUCT LINE
SPECTRAL MEDICAL INC.
CARDIAC REAGENTS
Spectral’s cardiac protein portfolio covers the two most clinically significant biomarker categories in cardiovascular testing: cardiac Troponin (cTnI-C and cTnI-C-II) and NT-proBNP.
MEASURING ENDOTOXIN
EAA™ ENDOTOXIN ACTIVITY ASSAY
ENDOTOXIN ACTIVITY ASSAY
EAA™
The only Health Canada licensed, FDA cleared, and CE marked rapid diagnostic for endotoxin activity in human whole blood.
Endotoxin is an early objective marker for severity of sepsis that may not be identified with traditional clinical signs.
Endotoxin is the most important microbial mediator of sepsis, yet, until the EAA™, there has been no reliable method to measure it accurately in the blood stream.
EAA™
The EAA™ received FDA clearance in 2003 following the MEDIC (Multi-Center Endotoxin Detection in Critical Illness) clinical trial, demonstrating that higher EAA™ results are correlated with a higher risk of mortality, as well as an increasing risk for developing sepsis. The EUPHRATES trial demonstrated that EAA™ can be used as a diagnostic to drive anti-endotoxin therapy in septic shock patients.
Aside from its approved clinical use, EAA™ is becoming the gold standard for the measurement of endotoxin (LPS) activity, and is commonly utilized in various research studies focused on the role of endotoxin in disease development in both human and animal models.
EAA™ for Clinicians
Endotoxin is a major component of the cell wall of Gram Negative bacteria and is an important microbial mediator of sepsis.
EAA™ for Researchers
The Endotoxin Activity Assay (EAA™) is the gold standard for measuring Endotoxin Activity in human whole blood, and has been utilized in human and veterinary research projects around the world.
READ MORE >
